Aldurazyme laronidase: Phase III results; BLA under review

Six-month extension data from a previously reported international Phase III trial in 45 patients with MPS I showed that Aldurazyme treatment

Read the full 219 word article

How to gain access

Continue reading with a
two-week free trial.